Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2025-12-25 @ 1:22 AM
NCT ID:
NCT00281593
Eligibility Criteria:
Inclusion Criteria:
* Male and female patients \>=18 years of age with Stage I or II hypertension defined as:
* a mean seated cuff diastolic blood pressure \>=95 and \<=119 mmHg Main
Exclusion Criteria:
* Pregnant
* breast-feeding
* unwilling to use birth control during the study
* secondary hypertension
* SBP\>=180 mmHg
* DBP\>=120 mmHg
* severe renal dysfunction
* hepatic insufficiency
* stroke within the last 6 months
* myocardial infarction, cardiac surgery, percutaneous transluminal coronary angioplasty, unstable angina or coronary artery bypass graft within the past three months
* unstable or uncontrolled diabetes
* history of angioedema of either of the study drugs, and hypersensitivity to the study drugs.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00281593
Study Brief:
Protocol Section:
NCT00281593